Paul J. Hastings
Chief Executive Officer at Nkarta Inc.
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Nkarta Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nkarta Inc. June 13, 202489.1%
-
enGene Therapeutics Inc. May 15, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Nkarta Inc. | Open-market sale | −1,776 | $2.71 | $4,813 |
| Jan 15, 2026 | Nkarta Inc. | Open-market sale | −26,046 | $2.07 | $53,915 |
| Jan 6, 2026 | Nkarta Inc. | Grant or award | +94,000 | — | — |
| Jun 18, 2025 | Nkarta Inc. | Open-market sale | −1,790 | $1.79 | $3,204 |
| Jan 15, 2025 | Nkarta Inc. | Open-market sale | −17,378 | $2.20 | $38,232 |
| Jan 3, 2025 | Nkarta Inc. | Grant or award | +94,500 | — | — |
| Jun 18, 2024 | Nkarta Inc. | Open-market sale | −1,770 | $5.60 | $9,912 |
| Jun 13, 2024 | Pacira BioSciences Inc. | Open-market sale | −880 | $28.38 | $24,974 |
| Jun 12, 2024 | Pacira BioSciences Inc. | Grant or award | +5,230 | — | — |
| Mar 4, 2024 | Nkarta Inc. | Sold back to the company | −137,642 | $13.33 | $1,834,768 |
| Mar 1, 2024 | Nkarta Inc. | Sold back to the company | −12,358 | $13.00 | $160,654 |
| Jan 16, 2024 | Nkarta Inc. | Open-market sale | −9,697 | $8.74 | $84,752 |
| Jan 4, 2024 | Nkarta Inc. | Grant or award | +85,000 | — | — |
| Jun 20, 2023 | Nkarta Inc. | Open-market sale | −1,704 | $4.85 | $8,264 |
| Jun 14, 2023 | Pacira BioSciences Inc. | Grant or award | +1,775 | — | — |
Questions about Paul J. Hastings
What boards is Paul J. Hastings on?
Paul J. Hastings sits on the boards of Adial Pharmaceuticals Inc, Nkarta Inc., Pacira BioSciences Inc. and enGene Therapeutics Inc.
What company is Paul J. Hastings the CEO of?
Paul J. Hastings is Chief Executive Officer of Nkarta Inc.
How long has Paul J. Hastings served on boards?
Our records show at least 10 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.